Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hershko

Showing results (1-10 of 211) with videos related to

Pageof 22
Sort By:
Seminars in Hematology|October 1, 1989
Mechanism of iron toxicity and its possible role in red cell membrane damageC Hershko
Medecine & Chirurgie Digestives|January 1, 1972
Hepatic vein thrombosis in children in the Near EastC Hershko
Bailliere'S Clinical Haematology|December 1, 1994
Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelatorsC Hershko
Haematologica|June 1, 1975
Pathogenesis and management of iron overload in thalassemiaC Hershko
Seminars in Hematology|April 23, 2005
Treating iron overload: the state of the artC Hershko
British Medical Journal (Clinical Research Ed.)|April 16, 1988
Oral iron chelating drugs: coming but not yet ready for clinical useC Hershko
Harefuah|January 1, 1974
[Editorial: Anemia of inflammation]C Hershko
Lancet (London, England)|April 24, 1993
Development of oral iron chelator L1C Hershko
The Proceedings of the Nutrition Society|February 1, 1993
Iron, infection and immune functionC Hershko
Molecular Aspects of Medicine|January 1, 1992
Iron chelators in medicineC Hershko
Pageof 22

Showing results (1-10 of 211) with videos related to

Sort By:
Pageof 22
Seminars in Hematology|October 1, 1989
Mechanism of iron toxicity and its possible role in red cell membrane damageC Hershko
Medecine & Chirurgie Digestives|January 1, 1972
Hepatic vein thrombosis in children in the Near EastC Hershko
Bailliere'S Clinical Haematology|December 1, 1994
Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelatorsC Hershko
Haematologica|June 1, 1975
Pathogenesis and management of iron overload in thalassemiaC Hershko
Seminars in Hematology|April 23, 2005
Treating iron overload: the state of the artC Hershko
British Medical Journal (Clinical Research Ed.)|April 16, 1988
Oral iron chelating drugs: coming but not yet ready for clinical useC Hershko
Harefuah|January 1, 1974
[Editorial: Anemia of inflammation]C Hershko
Lancet (London, England)|April 24, 1993
Development of oral iron chelator L1C Hershko
The Proceedings of the Nutrition Society|February 1, 1993
Iron, infection and immune functionC Hershko
Molecular Aspects of Medicine|January 1, 1992
Iron chelators in medicineC Hershko
Pageof 22